Back to catalogue
№ 221 24 filings · 2022-04-06 → 2026-09-21

GETECH GROUP PLC

GTC
Energy Share price 4.40p Market cap £6.73m Overall fit 340 /1000

Weak AI-receiver angle (uses AI internally but doesn't capture AI-driven value chain spend) and fragile balance sheet cap the score, despite genuine operating leverage and roughly fair current pricing. Not a natural fit for the strategy but the operating-leverage pillar and reasonable valuation prevent it dropping into the poor-fit band.

Fair value range 4p–6p Mid case · £6.90m
Absolute upside +2.6% vs current market cap
Conviction 2/5 confidence in fair call
Supports the call
  • Clean, consistent recent disclosures under new management
  • Multiple valuation approaches (ARR, EV/EBITDA, sales) converge on similar range
  • External validation from Xcalibur 25.5% strategic stake
Limits the call
  • Tiny mcap makes fair-value range wide in relative terms and highly sensitive to contract timing
  • Only 12-18 months of clean turnaround delivery; historical volatility high
Methodology

Blend of forward ARR multiple, EV/EBITDA and revenue multiple

In one line · bull case

Genuine sub-scale turnaround with valuable proprietary geoscience data assets, growing ARR and operating leverage — roughly fair-to-modestly-cheap at the current price with strategic-buyer optionality from Xcalibur's 25.5% stake.

In one line · biggest risk

Thin liquidity (£0.6m cash) leaves no room for a single project slippage or working-capital shock without further dilution.

Drivers
AI beneficiary 25 /100
Uses AI/ML tools internally on Globe but is not an AI value-chain beneficiary; end markets are oil & gas, mining, natural hydrogen.
Operating leverage 75 /100
Capital-light data/software model, largely fixed cost base explicitly flagged by management; 70-80% incremental contribution margin plausible on new subscriptions.
Earnings vs expectations 55 /100
In-line under current management since Jan 2025 but only four reporting periods of clean delivery; not enough data for higher score.
Growth momentum 60 /100
Revenue +15% H1 2026 YoY, ARR £2.8m -> £3.0m post-period, order book £4.7m; momentum is improving but off a stagnant multi-year base.
Moat 55 /100
40+ year global gravity/magnetics database is genuinely hard to replicate; scale is small but strategic (Xcalibur bought 25.5%).
Earnings quality 55 /100
Clean reporting, cash conversion improving materially in H1 2026, but small absolute cash flows make quality hard to fully assess.
Management quality 50 /100
New team since Jan 2025 executing the turnaround credibly; prior team overextended into H2 Green with poor capital allocation.
Cyclicality 65 /100
Highly exposed to oil & gas exploration capex and mining cycles; 2023 revenue drop of 21% demonstrated sensitivity.
Leverage 25 /100
Modest financial leverage (~£0.1m borrowings) but very thin liquidity cushion (£0.6m cash) and net current liabilities.
Value-trap signals · 4
  • Revenue effectively flat over five-year period (£5.1m 2021 -> £5.0m 2025)
  • Sub-scale operator competing with much larger seismic/data peers
  • Historical going-concern emphasis of matter in 2023 audit
  • Repeated equity dilution to fund turnaround (£1.7m at 2p in Aug 2024)

GETECH GROUP PLC (GTC) — Investment Research Note

Executive summary

Getech is a UK-listed AIM micro-cap that sells proprietary geoscience data, the Globe subsurface platform, and expert services used by oil & gas majors, miners, and (increasingly) natural hydrogen explorers to locate subsurface resources. Over the past five years the business has shrunk from £5.1m revenue in 2021 to £4.0m in 2023, then rebuilt to £5.0m in 2025 and £2.4m in H1 2026 (+15% YoY), with cost base cut ~20% in H1 2025 delivering the first EBITDA-positive halves since 2019. The single most important valuation point today is that a 15%-growth, £5m-mcap, cash-lean, £3m-ARR business is roughly fairly priced — the equity has already run 80% in a year — and the thesis for further re-rating rests on ARR growth and the strategic value of the proprietary G&M database, now partly validated by Xcalibur taking a 25.5% stake in July 2026.

Fair value estimate

  • Fair value range: 3.5p – 5.5p per share; implied market cap £5.3m – £8.4m (GBP)
  • Methodology: Blend of (i) 2.0–2.5x forward ARR of ~£3.0m; (ii) 1.0–1.5x FY26E revenue of ~£5.5m; (iii) cross-check on modest EV/EBITDA of 8–10x on annualised adj. EBITDA run-rate of ~£0.6–0.8m 2026-09 interim, 2026-04 final results.
  • Key assumptions: ARR grows to £3.3–3.6m by end-FY26 as pipeline converts; adj. EBITDA £0.5–0.8m for FY26; no takeover premium embedded despite Xcalibur's 25.5% strategic holding.
  • Current mcap £5.0m sits at the very bottom of the range.
  • Absolute upside/(downside): +38% to mid (4.5p); +69% to top (5.5p); +8% to low (3.5p).

Sector context

  • ICB classification "Energy" is technically correct but misleading — Getech is a data/software vendor to the energy exploration value chain, not a hydrocarbon producer.
  • Quality profile is below typical AIM software peers (sub-scale, historically loss-making, thin balance sheet) but the proprietary global gravity & magnetics database is a genuinely rare asset.
  • Closest listed comparables: CGG (Viridien), PGS, TGS (all seismic/subsurface data at vastly larger scale). Also loosely: Sound Energy (JV partner), Cornish Metals (small AIM natural resources).

Investment thesis (3 bullets)

  1. Genuine turnaround delivering measurable operating leverage. Cost base cut ~£1m annualised in H1 2025 (~20%), and combined with 15% revenue growth this flipped H1 EBITDA from -£0.1m to +£0.2m and generated £0.9m of operating cash 2026-09-21 interim results. Management explicitly flags "largely fixed cost base provides the potential for meaningful operational leverage as revenues expand."
  2. Strategic scarcity of the proprietary data asset, now externally validated. 40+ years of harmonised global gravity & magnetics data plus the Globe platform (15 years of build) — five of the six oil & gas supermajors are now Globe subscribers, and Xcalibur Multiphysics took a 25.5% shareholding in July 2026 2026-09-21 interim. Board explicitly states current price does not reflect data/IP value.
  3. Optionality on natural hydrogen at capital-light cost. European Commission natural hydrogen consortium contract worth €1m over FY26-FY27, HyMaroc JV with Sound Energy, and a growing pipeline — Getech is positioned as one of the few incumbents with the geophysical toolkit to locate this emerging resource 2026-09-21 interim; 2026-04-30 final results.

Key risks (3 bullets)

  1. Fragile balance sheet. Cash of just £0.6m at 30 June 2026, net current liabilities of £0.7m, historical going-concern emphasis of matter in the 2023 audit report 2024-06 final results. Any working-capital shock (delayed customer receipt, single contract slippage) could force dilution.
  2. Cyclical, concentrated end-market exposure. ~66% of FY2025 revenue from transitional petroleum; sales dropped 21% in 2023 on oil & gas capex retrenchment 2024-06 final results. Small customer base means single project slippage is material — H2 2023 profit warning was driven by exactly this.
  3. Xcalibur stake creates governance uncertainty. A 25.5% strategic holder acquired just weeks after the H1 result is either the first step toward an approach on the cheap or a strategic partnership that de-risks the business — the board describes "engaging constructively" 2026-09-21 interim. Minorities could be squeezed at a modest premium.

Operating leverage

Getech has a classic high-fixed-cost, capital-light software/data economics profile. Total cost base excluding exceptionals was £5.2m in FY2025 and roughly flat in H1 2026 at £2.4m — the marginal cost of an incremental Globe subscription or renewal is near zero. Gross margin (ex-amortisation) improved from 63% in H1 2025 to 65% in H1 2026 2026-09-21 interim. The March 2026 Asian NOC renewal at a 28% price uplift shows real pricing power on existing contracts. On a £5.5m revenue base, we estimate incremental contribution margin on new subscriptions is 70–80%: a hypothetical 15–20% revenue beat (~£0.8–1.1m of additional revenue) could add £0.6–0.9m of EBITDA — roughly 2–3x the FY25 EBITDA level. The clear observable inflection point is ARR breaching the £4.8m fixed cost base, at which the business becomes sustainably free-cash-flow generative. Management's key stated KPI is precisely this: "growing ARR ahead of cost base." However, absolute scale is tiny — even generous operating leverage on £5m revenue produces sub-£1m of profit, capping the leverage in absolute cash terms.

Value-trap signals

  • Structural revenue stagnation: Revenue was £5.1m in 2021, £4.7m in 2024, £5.0m in 2025 — five years of flat-to-declining trajectory with one restructure in between. Growth is only just resuming.
  • Sub-scale in a market with vastly larger competitors (TGS, Viridien) — the moat is real but the moat protects a small pond.
  • Historical going-concern emphasis of matter in FY23 audit report.
  • Repeated dilution — £1.7m placing at 2p in August 2024, prior fundraise of £6.25m in 2021, both dilutive to legacy holders.

Earnings vs. expectations

The pattern across five years is: frequent misses in 2022–2023 when strategy was overextended into H2 Green (green hydrogen developer), followed by consistent in-line-or-modest-beat delivery under the new CEO from Jan 2025 onward. The Dec 2023 trading update was a clear profit warning (annual revenue guided down to £4.0–4.4m vs. prior expectations, delays in customer projects). Subsequent updates (Jan 2026, July 2026) delivered in-line results consistent with prior guidance, with FY25 revenue landing at £5.0m matching Jan 2026 preliminary numbers, and H1 2026 revenue of £2.4m/EBITDA £0.2m confirmed exactly at trading update stage. The pattern is "cleaner under current management, but only four quarters of clean delivery" — not enough for high-conviction beat/miss scoring.

Conviction

Conviction: 2 (low)

Anchoring factors: (1) the disclosures are reasonably clean and the recent trading pattern is consistent; (2) multiple independent valuation approaches (ARR multiple, EV/EBITDA, revenue multiple) converge in a similar range. Limiting factors: (1) the absolute mcap is tiny, so the fair-value range is £5–8m — wide in relative terms and any single contract materially moves it; (2) the Xcalibur strategic stake creates unpredictable optionality that could cap or extend the upside; (3) the switch from "loss-making, going-concern warned" to "EBITDA-positive turnaround" is only 12–18 months old.

Filings consulted · 32

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-21Interim Results2026-09-21_9780690_interim-results.md0.90
  2. 2026-09-18Notice OF Results Amp Investor Presentation2026-09-18_9778565_notice-of-results-amp-investor-presentation.md0.70
  3. 2026-07-14Trading Statement2026-07-14_9666598_trading-statement.md0.85
  4. 2026-06-02Result OF Agm2026-06-02_9597442_result-of-agm.md0.30
  5. 2026-05-08Notice OF Agm2026-05-08_9558252_notice-of-agm.md0.30
  6. 2026-04-30Final Results2026-04-30_9545304_final-results.md1.00
  7. 2026-01-20Trading Statement2026-01-20_9367597_trading-statement.md0.72
  8. 2025-09-24Half Year Report2025-09-24_9127290_half-year-report.md0.77
  9. 2025-07-24Trading Statement2025-07-24_8996318_trading-statement.md0.55
  10. 2025-05-29Result OF Agm2025-05-29_8903557_result-of-agm.md0.20
  11. 2025-05-06Final Results2025-05-06_8860737_final-results.md0.65
  12. 2025-01-20Trading Update2025-01-20_8695472_trading-update.md0.55
  13. 2024-09-23Half Year Report2024-09-23_8431263_half-year-report.md0.58
  14. 2024-08-09Result OF Placing And Subscription2024-08-09_8359341_result-of-placing-and-subscription.md0.32
  15. 2024-08-08Placing And Subscription TO Raise UP TO 1 5M2024-08-08_8357857_placing-and-subscription-to-raise-up-to-1-5m.md0.32
  16. 2024-06-28Posting OF Annual Report Amp Accounts2024-06-28_8285159_posting-of-annual-report-amp-accounts.md0.43
  17. 2024-06-27Result OF Agm2024-06-27_8282539_result-of-agm.md0.14
  18. 2024-06-20Final Results2024-06-20_8268794_final-results.md0.45
  19. 2024-06-06Notice OF Agm2024-06-06_8245129_notice-of-agm.md0.14
  20. 2023-12-15Trading Update2023-12-15_7943810_trading-update.md0.38
  21. 2023-09-25Interim Results2023-09-25_7773837_interim-results.md0.41
  22. 2023-09-18Notice OF Results And Investor Presentations2023-09-18_7761726_notice-of-results-and-investor-presentations.md0.17
  23. 2023-06-29Result OF Agm2023-06-29_7603559_result-of-agm.md0.07
  24. 2023-06-05Final Results2023-06-05_7558424_final-results.md0.25
  25. 2023-06-02Notice OF Results And Investor Presentation2023-06-02_7556380_notice-of-results-and-investor-presentation.md0.17
  26. 2023-01-25Notice OF Investor Presentation2023-01-25_7227302_notice-of-investor-presentation.md0.17
  27. 2023-01-23Post Close Trading Update2023-01-23_7473452_post-close-trading-update.md0.21
  28. 2022-09-28Interim Results2022-09-28_7125228_interim-results.md0.23
  29. 2022-06-23Result OF Agm2022-06-23_7069077_result-of-agm.md0.07
  30. 2022-05-19Investor Presentation2022-05-19_6933159_investor-presentation.md0.17
  31. 2022-05-19Final Results2022-05-19_6933070_final-results.md0.25
  32. 2022-04-06Trading Update And Outlook2022-04-06_6862175_trading-update-and-outlook.md0.21

This research note was authored by a large language model after reading 24 regulatory filings published between 2022-04-06 and 2026-09-21. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.